Cargando…
Oestrogen receptor negativity in breast cancer: a cause or consequence?
Endocrine resistance, which occurs either by de novo or acquired route, is posing a major challenge in treating hormone-dependent breast cancers by endocrine therapies. The loss of oestrogen receptor α (ERα) expression is the vital cause of establishing endocrine resistance in this subtype. Understa...
Autores principales: | Gajulapalli, Vijaya Narasihma Reddy, Malisetty, Vijaya Lakshmi, Chitta, Suresh Kumar, Manavathi, Bramanandam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180249/ https://www.ncbi.nlm.nih.gov/pubmed/27884978 http://dx.doi.org/10.1042/BSR20160228 |
Ejemplares similares
-
Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development
por: Manavathi, Bramanandam, et al.
Publicado: (2014) -
MTA family of coregulators in nuclear receptor biology and pathology
por: Manavathi, Bramanandam, et al.
Publicado: (2007) -
Effective in vitro delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug dose
por: Medhi, Himadri, et al.
Publicado: (2020) -
The origins of oestrogen receptor negative breast cancer
por: Allred, D Craig
Publicado: (2007) -
Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)